Similar articles

• [Survival of tuberculous bacilli in combined treatments including rifampicin].

  Kreis B, Pretet S. Kreis B, et al. Rev Tuberc Pneumol (Paris). 1970 Apr-May;34(3):429-33. Rev Tuberc Pneumol (Paris). 1970. PMID: 4994940 French. No abstract available.
• [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].

  Adamovich VN, Kolomytseva OS, Gur'ian IE. Adamovich VN, et al. Vrach Delo. 1975 Jan;(1):95-9. Vrach Delo. 1975. PMID: 806177 Russian. No abstract available.
• [Rifamicin in the studies of the Scuola Tisiologica in Naples].

  Nitti V. Nitti V. Arch Tisiol Mal Appar Respir. 1968 Apr;23(4):271-92. Arch Tisiol Mal Appar Respir. 1968. PMID: 4981409 Italian. No abstract available.
• Bacteriologic basis of short-course chemotherapy for tuberculosis.

  Grosset J. Grosset J. Clin Chest Med. 1980 May;1(2):231-41. Clin Chest Med. 1980. PMID: 6794976 Review. No abstract available.
• Summation of experimental studies on the action of rifampin.

  Hobby GL. Hobby GL. Chest. 1972 Jun;61(6):550-4. doi: 10.1378/chest.61.6_supplement.550. Chest. 1972. PMID: 4624277 Review. No abstract available.